Literature DB >> 3084490

Interaction of thrombospondin with resting and stimulated human platelets.

R Wolff, E F Plow, M H Ginsberg.   

Abstract

The interaction of isolated and radioiodinated thrombospondin with washed human platelets has been characterized. The ligand bound to nonstimulated and thrombin-stimulated platelets in a time-dependent manner, and apparent steady state was reached within 25 min. Binding was not due to iodination of the ligand and was inhibited by nonlabeled thrombospondin but not by unrelated proteins, and bound ligand was identical with thrombospondin in terms of subunit structure. Nonlinear curve-fitting analyses of binding to resting platelets suggested the presence of a single class of sites which bound 3,100 +/- 1,000 molecules/platelet with an apparent Kd of 50 +/- 20 nM. This interaction was not attributable to contaminating cells or inadvertant platelet activation. Binding to thrombin-stimulated platelets had a lower apparent affinity (Kd = 250 +/- 100 nM) and higher apparent capacity (35,600 +/- 9,600 molecules/platelet). Thrombin-enhanced binding was dependent upon agonist dose and platelet stimulation. Fibrinogen, a monoclonal antibody to GPIIb-IIIa, temperature, and divalent ions had differential effects upon thrombospondin binding to resting and stimulated platelets, suggesting the presence of two distinct mechanisms of thrombospondin binding to platelets. While thrombospondin binding to thrombin-stimulated platelets occurs with characteristics similar to those observed for fibrinogen, fibronectin, and von Willebrand Factor, its high affinity interaction with resting platelets is unique to this adhesive glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084490

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Thrombospondin as a mediator of cancer cell adhesion in metastasis.

Authors:  D A Walz
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

2.  Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins.

Authors:  F R Agbanyo; J J Sixma; P G de Groot; L R Languino; E F Plow
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

3.  Developmentally regulated expression of a 78 kDa erythroblast membrane glycoprotein immunologically related to the platelet thrombospondin receptor.

Authors:  N Kieffer; A Bettaieb; C Legrand; L Coulombel; W Vainchenker; L Edelman; J Breton-Gorius
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

4.  Identification of a new class of inducible receptors on platelets. Thrombospondin interacts with platelets via a GPIIb-IIIa-independent mechanism.

Authors:  M L Aiken; M H Ginsberg; E F Plow
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

5.  Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion.

Authors:  R L Silverstein; A S Asch; R L Nachman
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

6.  Thrombospondin-induced adhesion of human platelets.

Authors:  G P Tuszynski; M A Kowalska
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

7.  Molecular and functional differences induced in thrombospondin-1 by the single nucleotide polymorphism associated with the risk of premature, familial myocardial infarction.

Authors:  Natalya V Narizhneva; Vicky J Byers-Ward; Martin J Quinn; Frank J Zidar; Edward F Plow; Eric J Topol; Tatiana V Byzova
Journal:  J Biol Chem       Date:  2004-03-08       Impact factor: 5.157

8.  Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion.

Authors:  R L Silverstein; R L Nachman
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

9.  Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces.

Authors:  M Herrmann; S J Suchard; L A Boxer; F A Waldvogel; P D Lew
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

10.  The postmortem activation status of platelets.

Authors:  H Thomsen; B Krisch
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.